首页 | 本学科首页   官方微博 | 高级检索  
     

曲古抑菌素A促进去卵巢大鼠钛植入物骨整合
引用本文:周志 蒋文凯 刘之义 李杨 任茂贤 刘合栋 杨民. 曲古抑菌素A促进去卵巢大鼠钛植入物骨整合[J]. 中国骨质疏松杂志, 2023, 0(9): 1266-1,271
作者姓名:周志 蒋文凯 刘之义 李杨 任茂贤 刘合栋 杨民
作者单位:皖南医学院弋矶山医院创伤骨科,安徽 芜湖 241001
基金项目:国家自然科学基金资助项目(81341054,81171732);皖南医学院弋矶山医院科技攀峰计划(PF2019005);皖南医学院弋矶山医院人才引进基金(YR202226)
摘    要:目的 探讨TSA对去卵巢大鼠TI骨整合的影响。方法 将30只健康3月龄雌性SD大鼠随机分为Sham组(n=5)和OVX组(n=25)。正常饲养3个月后,两组各选取5只大鼠处死,取股骨远端样本行Micro-CT和HE染色以鉴定是否成功建立骨质疏松模型。随后在OVX组剩余大鼠双侧股骨干骺端植入直径1.5 mm TI,并将其分为2组:Control组(n=10)和TSA组(n=10)。连续给药4周。给药结束后处死全部大鼠并取股骨样本行Micro-CT扫描、HE染色以及Masson染色,ELISA法检测,拔钉实验。结果 与Sham组对比,Micro-CT显示OVX组BMD、BV/TV、Tb.Th、Tb.N降低(P<0.05),而Tb.Sp、SMI升高(P<0.05),HE染色显示OVX组骨小梁数量明显降低。与Control组对比,Micro-CT显示TSA组BMD、BV/TV、Tb.Th、Tb.N 、Conn.D均升高(P<0.05),而Tb.Sp、SMI降低(P<0.05),HE染色、Masson染色显示TSA组骨小梁数量、新生骨数量均升高,ELISA法检测结果显示TSA组OCN、BMP2均升高,拔钉实验显示TSA组TI轴向拔出力增大。结论 TSA通过上调OCN、BMP2等成骨相关蛋白,促进骨小梁形成和新骨形成,进而改善去卵巢大鼠TI骨整合。

关 键 词:曲古抑菌素A;去卵巢大鼠;钛植入物;骨质疏松;骨整合

Trichostatin A enhances titanium implant osseointegration in ovariectomized rats
ZHOU Zhi,JIANG Wenkai,LIU Zhiyi,LI Yang,REN Maoxian,LIU Hedong,YANG Min. Trichostatin A enhances titanium implant osseointegration in ovariectomized rats[J]. Chinese Journal of Osteoporosis, 2023, 0(9): 1266-1,271
Authors:ZHOU Zhi  JIANG Wenkai  LIU Zhiyi  LI Yang  REN Maoxian  LIU Hedong  YANG Min
Affiliation:Department of Traumatology and Orthopedics, Yijishan Hospital, Wannan Medial College, Wuhu 241001, Anhui, China
Abstract:Objective To investigate the effect of trichostatin A (TSA) on titanium implant (TI) osseointegration in ovariectomized rats. Methods 3-Month-old female Sprague-Dawley rats (n=30) were randomly divided into Sham group (n=5) and OVX group (n=25). After 3 months of normal feeding, 5 rats in each group were randomly selected and were sacrificed. The distal femurs were harvested for evaluation with high-resolution micro-CT. HE staining was used to verify the establishment of osteoporosis model. TI was inserted bilaterally in the femoral metaphyseal region of remaining rats in OVX group. All the TI implanted rats were randomly divided into 2 groups: Control group (n=10) and TSA group (n=10). The rats in TSA group were intraperitoneally injected trichostatin A for 4 weeks. The rats in Control group were intraperitoneally injected the same amount of normal saline. All the rats were sacrificed after the drug treatment and the distal femurs were harvested for evaluation with high-resolution micro-CT, HE staining, and Masson staining. The serum of the rats was examined using ELISA. Results Compared with those in Sham group, micro-CT results showed that bone mineral density (BMD), bone volume fraction (BV/TV), trabecular thickness (Tb.Th), trabecular number (Tb.N), and connective density (Conn.D) in OVX group decreased (P<0.05), and trabecular separation (Tb.Sp) and structure model index (SMI) increased (P<0.05) in OVX group. HE staining results showed that Tb.N in OVX group significantly decreased. Compared with those in the Control group, BMD, BV/TV, Tb.Th, and Tb.N increased in TSA group (P<0.05), and Tb.Sp and SMI decreased (P<0.05). HE staining and Masson staining results showed that Tb.N and new bone increased in TSA group. ELISA results showed that bone morphogenesis-related proteins bone morphogenetic protein-2 (BMP2) and serum osteocalcin (OCN) increased in TSA group. Conclusion TSA improves TI implant osseointegration by promoting bone trabecular formation in OVX rats by up-regulating the key proteins of bone formation OCN and BMP2.
Keywords:trichostatin A   ovariectomized rats   titanium implants   osteoporosis   osseointegration
点击此处可从《中国骨质疏松杂志》浏览原始摘要信息
点击此处可从《中国骨质疏松杂志》下载全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号